Effect of vessels that encapsulate tumor clusters (VETC) on the prognosis of different stages of hepatocellular carcinoma after hepatectomy

肝细胞癌 医学 内科学 肝切除术 肿瘤科 外科 切除术
作者
Yanyan Wang,Kun Dong,Kun Wang,Yu Sun,Baocai Xing
出处
期刊:Digestive and Liver Disease [Elsevier BV]
卷期号:55 (9): 1288-1294 被引量:6
标识
DOI:10.1016/j.dld.2023.03.008
摘要

Background Vessels that encapsulate tumor clusters (VETC) is a newly discovered vascular pattern in hepatocellular carcinoma (HCC), representing high biological aggressiveness. However, it remains unclear whether the prognostic impact of VETC differs in patients with different staged HCC. This study aimed to evaluate the effect of VETC on the prognosis of patients with HCC at different stages after hepatectomy. Methods Patients who underwent hepatectomy for HCC between January 2005 and December 2019 were assessed, and stratified according to their Barcelona Clinic Liver Cancer (BCLC) stage. Overall survival (OS) and disease-free survival (DFS) were compared between patients with and without VETC. Independent risk factors of OS and DFS were determined by multivariable Cox regression analyses. Results A total of 837 consecutive patients undergoing curative hepatectomy were enrolled, and VETC pattern was found in 339 (40.5%) patients. The incidence of VETC in patients at BCLC-0, BCLC-A, BCLC-B and BCLC-C stage was 17.8%, 40.2%, 53.7% and 66.0%, respectively. In the entire patients, VETC+ patients had significantly lower OS and DFS than VETC- patients. After stratification of patients according to BCLC stage, VETC was associated with worse OS and DFS only in patients at BCLC-A and BCLC-B stages, but not in those at BCLC-0 and BCLC-C stages. Multivariable analyses also revealed that VETC was an independent risk factor for OS and DFS in both the patients at BCLC-A and BCLC-B stages. Conclusions VETC is associated with poor OS and DFS in patients with HCC at BCLC-A and BCLC-B stage after hepatectomy, but it does not affect the survival of patients with HCC at BCLC-0 and BCLC-C stage after hepatectomy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.4应助sj采纳,获得10
1秒前
2秒前
999完成签到,获得积分10
2秒前
柔弱的老三完成签到 ,获得积分10
3秒前
田様应助柴柴采纳,获得10
3秒前
4秒前
pluto应助快乐的饼干采纳,获得55
4秒前
4秒前
脑洞疼应助科研通管家采纳,获得10
5秒前
打打应助科研通管家采纳,获得10
5秒前
arniu2008应助科研通管家采纳,获得20
5秒前
英俊的铭应助科研通管家采纳,获得10
5秒前
大个应助科研通管家采纳,获得10
5秒前
深情安青应助科研通管家采纳,获得10
5秒前
彭于晏应助科研通管家采纳,获得10
6秒前
完美世界应助科研通管家采纳,获得10
6秒前
Ava应助科研通管家采纳,获得10
6秒前
汉堡包应助科研通管家采纳,获得10
6秒前
Alex应助科研通管家采纳,获得20
6秒前
斯文败类应助科研通管家采纳,获得10
6秒前
思源应助科研通管家采纳,获得10
6秒前
6秒前
6秒前
田様应助科研通管家采纳,获得10
6秒前
无花果应助科研通管家采纳,获得30
6秒前
烟花应助科研通管家采纳,获得10
6秒前
SciGPT应助科研通管家采纳,获得10
7秒前
8秒前
英俊的铭应助LuQihe采纳,获得10
8秒前
自然醒发布了新的文献求助20
10秒前
JamesPei应助蘑菇采纳,获得10
11秒前
zz发布了新的文献求助10
11秒前
11秒前
12秒前
搜集达人应助sj采纳,获得10
12秒前
天天快乐应助sj采纳,获得10
12秒前
mm发布了新的文献求助10
12秒前
12秒前
斯文败类应助sj采纳,获得10
12秒前
小马甲应助sj采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Cronologia da história de Macau 5000
咳嗽・喀痰の診療ガイドライン第2版2025 800
Petrology and Plate Tectonics 800
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
The globalisation of real estate: the politics and practice of foreign real estate investment 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 光电子学 物理化学 电极 基因 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 7000260
求助须知:如何正确求助?哪些是违规求助? 8675615
关于积分的说明 18394931
捐赠科研通 6477264
什么是DOI,文献DOI怎么找? 3100507
关于科研通互助平台的介绍 2165144
邀请新用户注册赠送积分活动 2076852